The U.S. Army Edgewood Chemical Biological Center (ECBC), and the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) last month officially opened a new Proteomics Core Facility at Aberdeen Proving Ground, MD.
The organizations collaborated to design a shared working space to meet expanding requirements for proteomics and genomics research at each institution.
“Rather than duplicate the capabilities, why not build them in one joint facility?” said Jennifer Sekowski, Ph.D., Molecular Toxicologist and ECBC lead for standing up the Proteomics Core Facility. “Having a combined Genomics and Proteomics Core now allows us to more easily share our resources, provide new training opportunities, and expand the amount and type of research we both can do.” (Source: U.S. Army)
The facility will support biological research into a variety of Chemical, Biological, Radiological, Nuclear and high-yield Explosives (CBRNE) issues. Newly-added equipment will help advance research utilizing mass spectrometry-based proteomics, high content image analysis of cells and tissues, whole genomic sequencing and finishing, expression analysis and microRNA.
The Proteomics Core Facility is part of Aberdeen’s state-of-the-art McNamara Life Sciences Research Facility which also houses ECBC’s High-Containment Biosafety Level 3 (BSL-3) Laboratory and Special Containment Facility.
